2-ETHOXYETHYL 2-CYANO-3-((3-(4-METHOXYPHENYL)ISOXAZOL-5-YL)METHYLAMINO)-4-METHYLPENT-2-ENOATE

/static/temp/default.svg

Search structure


Source	Gaulton A, Kale N, van Westen GJ, Bellis LJ, Bento AP, Davies M, Hersey A, Papadatos G, Forster M, Wege P, Overington JP. A large-scale crop protection bioassay data set. Sci Data. 2015 Jul 7;2:150032. Read more ...


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Structure


InChI Key	KJUKYHCZLLOWSQ-VZCXRCSSSA-N
Smiles	CCOCCOC(=O)\C(=C(/NCc1onc(c1)c2ccc(OC)cc2)\C(C)C)\C#N
InChI	InChI=1S/C22H27N3O5/c1-5-28-10-11-29-22(26)19(13-23)21(15(2)3)24-14-18-12-20(25-30-18)16-6-8-17(27-4)9-7-16/h6-9,12,15,24H,5,10-11,14H2,1-4H3/b21-19-

Physicochemical Descriptors

Property Name	Value
Molecular Formula	C22H27N3O5
Molecular Weight	413.47
AlogP	3.1
Hydrogen Bond Acceptor	7.0
Hydrogen Bond Donor	1.0
Number of Rotational Bond	12.0
Polar Surface Area	106.61
Molecular species	NEUTRAL
Aromatic Rings	2.0
Heavy Atoms	30.0

Assay Description	Organism	Bioactivity	Reference
Herbicidal activity against Amaranthus retroflexus assessed as inhibition of weed growth at 75 g/ha using postemergence treatment protocol	Amaranthus retroflexus	65.2 %
Herbicidal activity against Amaranthus retroflexus assessed as inhibition of weed growth at 150 g/ha using postemergence treatment protocol	Amaranthus retroflexus	93.5 %
Herbicidal activity against Amaranthus retroflexus assessed as inhibition of weed growth at 375 g/ha using postemergence treatment protocol	Amaranthus retroflexus	100.0 %
Herbicidal activity against Amaranthus retroflexus assessed as inhibition of weed growth at 750 g/ha using postemergence treatment protocol	Amaranthus retroflexus	100.0 %
Herbicidal activity against Brassica napus (oilseed rape) assessed as inhibition of weed growth at 75 g/ha using postemergence treatment protocol	Brassica napus	82.5 %
Herbicidal activity against Brassica napus (oilseed rape) assessed as inhibition of weed growth at 150 g/ha using postemergence treatment protocol	Brassica napus	100.0 %
Herbicidal activity against Brassica napus (oilseed rape) assessed as inhibition of weed growth at 375 g/ha using postemergence treatment protocol	Brassica napus	100.0 %
Herbicidal activity against Brassica napus (oilseed rape) assessed as inhibition of weed growth at 750 g/ha using postemergence treatment protocol	Brassica napus	100.0 %
Herbicidal activity against Brassica napus (oilseed rape) assessed as inhibition of weed growth at 1.5 kg/ha using preemergence treatment protocol	Brassica napus	40.9 %
Herbicidal activity against Digitaria sanguinalis (hairy crabgrass) assessed as inhibition of weed growth at 1.5 kg/ha using pre-emergence treatment protocol	Digitaria sanguinalis	0.0 %
Herbicidal activity against Echinochloa crus-galli (barnyard grass) assessed as inhibition of weed growth at 1.5 kg/ha using preemergence treatment protocol	Echinochloa crus-galli	0.0 %
Herbicidal activity against Amaranthus retroflexus assessed as inhibition of weed growth at 1.5 kg/ha using preemergence treatment protocol	Amaranthus retroflexus	45.2 %
Herbicidal activity against Brassica napus (oilseed rape) assessed as inhibition of weed growth at 1.5 kg/ha using postemergence treatment protocol	Brassica napus	100.0 %
Herbicidal activity against Echinochloa crus-galli (barnyard grass) assessed as inhibition of weed growth at 1.5 kg/ha using postemergence treatment protocol	Echinochloa crus-galli	0.0 %
Herbicidal activity against Digitaria sanguinalis (hairy crabgrass) assessed as inhibition of weed growth at 1.5 kg/ha using post-emergence treatment protocol	Digitaria sanguinalis	14.3 %
Herbicidal activity against Amaranthus retroflexus assessed as inhibition of weed growth at 1.5 kg/ha using postemergence treatment protocol	Amaranthus retroflexus	100.0 %

Cross References

Resources	Reference
ChEMBL	CHEMBL2227882
PubChem	45277796

CONTENTS

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).